Please enable Javascript to get a taste of that Hopium 👼

ABT - Financials Overview - Abbott Laboratories

Financials

We've grouped the latest 4 financial reports for ABT. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2018201920202021
Total Revenue$29.6B$31.2B$34.1B$42.5B
Cost of Revenue$24.6B$24.9B$26.9B$32.0B
Gross Margin$15.7B$16.7B$7.20B$10.6B
Research & Development$2.30B$2.44B$2.42B$2.74B
Selling, General and Administrative----
Other Operating Expense----
Total Operating Expense----
Operating Income$3.65B$4.53B$5.36B$8.43B
Interest Income$105M$94.0M-$492M-$491M
Interest Expense$826M$670M$546M$533M
Net Interest Incomee-$826M-$670M-$546M-$533M
Other Income Expense----
Non-recurring Items----
Other Non-operating Income$139M$191M$103M$277M
Income before Provision for income taxes$2.91B$4.08B$4.99B$8.21B
Tax Provision$539M$390M$497M$1.14B
Net Income$2.37B$3.69B$4.50B$7.07B
Effect of accounting charges----
Minority Interest----
Provision for income taxes----
Non-recurring items----
Other Items----
Discontinued Operations----
Preferred Stock Dividends----
EBIT$3.73B$4.75B$5.54B$8.74B
Balance Sheet2018201920202021
otherNonCurrentAssets----
Assets
Cash, Cash Equivalents & Short-term investments$4.09B$4.14B$7.15B$10.2B
Cash & Cash Equivalents----
Other Short-term Investments$242M$280M$310M$450M
Receivables----
Inventory$3.80B$4.32B$5.01B$5.16B
Other Current Assets$1.57B$1.79B$1.87B$2.35B
Total Current Assets$14.6B$15.7B$20.4B$24.2B
PPE$7.56B$8.04B$9.03B$8.96B
Non-current Marketable Securities$897M$883M$821M$816M
total non-current assets$50.8B$50.2B$49.5B$47.0B
Goodwill$23.3B$23.2B$23.7B$23.2B
Other Intangible Assets$42.2B$40.2B$38.5B$36.0B
deferred long-term asset charges----
Total Assets$67.2B$67.9B$72.5B$75.2B
Liabilities
Accounts Payable----
Current Debt$200M$201M$213M-
Other Current Liabilties$5.83B$6.13B$7.74B$7.94B
Total Current Liabilities$9.01B$10.9B$11.9B$13.1B
Long Term Debt$19.4B$17.9B$18.5B$18.1B
Non-Current Deferred Liabilties----
Negative Goodwill----
Other Non-Current Liabilities$3.98B$3.94B$3.68B$3.69B
total non-current liabilities$21.4B$20.2B$22.5B$21.0B
Total capital lease obligations-$755M$902M$956M
Total Liabilities$36.6B$36.8B$39.8B$39.4B
Shareholder's Equity
Common Stock----
Share premium----
Preferred Stock----
Retained Earnings----
Additional Paid-in Capital----
Gains/Losses not affecting retained earnings----
Treasury Stock$9.96B$10.1B$10.0B$11.8B
Total Shareholders' Equity$30.5B$31.1B$32.8B$35.8B
Total Liabilities and Shareholders' Equity----
Cash Flow2018201920202021
Cash from Operating Activities
Operating Activities$6.30B$6.14B$7.90B$10.5B
Other Operating Activities----
Change(increase) in Operating Activities----
Net Income$2.37B$3.69B$4.50B$7.07B
Depreciation----
Change in Liabilities----
Change in Inventory$514M$593M$493M$456M
Change(increase) in Account Receivables----
Change(increase) in Receivables$190M$275M$924M$383M
Cash from Investing Activities
Investment Activities-$1.36B-$1.81B-$2.21B-$2.01B
Other Investment Activities----
Investments----
Capital Expenditures$1.39B$1.64B$2.18B$1.89B
Cash from Financing Activities
Financing Activities-$10.4B-$4.29B-$2.78B-$5.49B
Other Financing Activities----
Stock Sale and Purchase----
Dividends$1.97B$2.27B$2.56B$3.20B
Net Borrowings----
Change(increase) in Cash----
Change(increase) in Cash and Cash Equivalents-$5.45B$32.0M$2.91B$3.03B
Change(increase) in Net Income----
Change in Exchange Rate----
Data source(s): Alpha Vantage